The Enterprise Value as of September 2024 (TTM) for Regen BioPharma, Inc. (RGBP) is 1.26M

According to Regen BioPharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.26M. This represents a change of -71.67% compared to the average of 4.46M of the last 4 quarters.

Regen BioPharma, Inc. (RGBP) Historical Enterprise Value (quarterly & annually)

How has RGBP Enterprise Value performed in the past?

The mean historical Enterprise Value of Regen BioPharma, Inc. over the last ten years is 19.27M. The current 1.26M Enterprise Value has changed 555.71% with respect to the historical average. Over the past ten years (40 quarters), RGBP's Enterprise Value was at its highest in in the September 2015 quarter at 31.53B. The Enterprise Value was at its lowest in in the June 2019 quarter at 1.99M.

Regen BioPharma, Inc. (RGBP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Regen BioPharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Regen BioPharma, Inc. (RGBP) Average Enterprise Value

How has RGBP Enterprise Value performed in the past?

The current Enterprise Value of Regen BioPharma, Inc. (RGBP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Regen BioPharma, Inc. (RGBP) Enterprise Value vs. Peers

How is RGBP’s Enterprise Value compared to its peers?

Regen BioPharma, Inc.’s Enterprise Value is greater than Oncology Pharma Inc. (82.17K), greater than Propanc Biopharma, Inc. (768.30K), greater than Kaleido Biosciences, Inc. (4.26K), greater than RegeneRx Biopharmaceuticals, Inc. (2.10K), greater than Creative Medical Technology Holdings, Inc. (-3122553.00), less than Theralink Technologies, Inc. (19.38M), less than Enzolytics Inc. (207.05M), less than Sonnet BioTherapeutics Holdings, Inc. (2.05M), less than PharmaTher Holdings Ltd. (0), less than Regen BioPharma, Inc. (20.41M), less than Mymetics Corporation (6.63M), less than ProtoKinetix, Incorporated (75.32M), less than Adynxx, Inc. (4.72M), less than Ascletis Pharma Inc. (0), greater than Eupraxia Pharmaceuticals Inc. (87.12K), less than AVAX Technologies, Inc. (884.65M), less than null (111.19M), greater than null (514.05K),

Build a custom stock screener for Regen BioPharma, Inc. (RGBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regen BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Regen BioPharma, Inc. (RGBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Regen BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.